2026-2034年獸用單株抗體全球市場規模、佔有率、趨勢和成長分析報告

預計獸藥市場的單株抗體市場將從 2025 年的 19.9 億美元成長到 2034 年的 99.3 億美元，2026 年至 2034 年的複合年成長率為 19.59%。

受寵物飼養量增加和對先進動物保健解決方案需求成長的推動，全球獸用單株抗體市場正經歷強勁成長。單株抗體因其在治療伴侶動物慢性疾病（如骨關節炎和皮膚病）方面的效用而獲得廣泛認可。寵物飼主對專業獸醫學的認知不斷提高，也顯著促進了市場擴張。

關鍵促進因素包括生物技術領域的技術進步、牲畜疾病日益普遍以及人們對動物福利的日益關注。製藥公司正大力投資研發，以開發安全性更高的標靶生物製藥。此外，獸用單株抗體療法的監管核准正在加速其商業化進程，並促進關鍵地區產品系列的擴展。

未來幾年，抗體工程和低成本生產流程的創新可望提升市場滲透率。隨著醫療基礎設施的擴展，新興市場蘊藏著巨大的未開發潛力。隨著精準醫療在動物保健領域蓬勃發展，單株抗體有望在改善治療效果和支持全球永續畜牧業方面發揮變革性作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球獸用單株抗體市場：依應用領域分類

• 市場分析、洞察與預測
• 皮膚科
• 疼痛
• 其他

第5章：全球獸用單株抗體市場：依動物類型分類

• 市場分析、洞察與預測
• 狗
• 其他

第6章：全球獸用單株抗體市場：依最終用戶分類

• 市場分析、洞察與預測
• 動物醫院
• 其他

第7章：全球獸用單株抗體市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Zoetis
  • Merck & Co Inc
  • Elanco
  • Boehringer Ingelheim GmbH
  • Indian Immunologicals Ltd
  • Virbac

The Monoclonal Antibodies In Veterinary Health Market size is expected to reach USD 9.93 Billion in 2034 from USD 1.99 Billion (2025) growing at a CAGR of 19.59% during 2026-2034.

The Global Monoclonal Antibodies in Veterinary Health Market is experiencing robust growth driven by rising pet ownership and increasing demand for advanced animal healthcare solutions. Monoclonal antibodies are gaining popularity for treating chronic conditions such as osteoarthritis and dermatological disorders in companion animals. Growing awareness among pet owners regarding specialized veterinary treatments is contributing significantly to market expansion.

Key drivers include technological advancements in biotechnology, increasing livestock disease prevalence, and a stronger focus on animal welfare. Pharmaceutical companies are investing heavily in research and development to create targeted biologics with improved safety profiles. Additionally, regulatory approvals for veterinary monoclonal antibody therapies are accelerating commercialization and expanding product portfolios across key regions.

In the coming years, innovation in antibody engineering and cost-effective manufacturing processes will strengthen market penetration. Emerging markets present significant untapped potential due to expanding veterinary healthcare infrastructure. As precision medicine gains momentum in animal health, monoclonal antibodies are expected to play a transformative role in improving treatment outcomes and supporting sustainable livestock production globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Dermatology
• Pain
• Others

By Animal Type

• Dogs
• Others

By End User

• Veterinary Hospitals
• Others

COMPANIES PROFILED

• Zoetis, Merck Co Inc, Elanco, Boehringer Ingelheim GmbH, Indian Immunologicals Ltd, Virbac
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Dermatology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Animal Type
• 5.2. Dogs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Veterinary Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Application
  • 7.2.2 By Animal Type
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Application
  • 7.3.2 By Animal Type
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Application
  • 7.4.2 By Animal Type
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Application
  • 7.5.2 By Animal Type
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Application
  • 7.6.2 By Animal Type
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Zoetis
  • 9.2.2 Merck & Co Inc
  • 9.2.3 Elanco
  • 9.2.4 Boehringer Ingelheim GmbH
  • 9.2.5 Indian Immunologicals Ltd
  • 9.2.6 Virbac